FCB Health launches next-generation big data agency by Beth Snyder Bulik Wednesday, October 17, 2018 FCB Health is looking to humanize data, formalizing that vision into its own distinct next generation big data agency named Solve(d).
FCB Health expands Area 23 with new combo agency by Beth Snyder Bulik Tuesday, September 11, 2018 FCB Health is leveraging its Area 23 brand, combining the name and award-winning talent with its medical communications expertise at Hudson Global.
Lights, camera, action for FCB Health spinout production studio by Beth Snyder Bulik Wednesday, August 22, 2018 Studio Rx is launching as a creative hub inside the FCB Health network to deliver film, animation and experiential projects in pharma and healthcare.
Cannes agency winner Area 23 spills secrets—or most of them by Beth Snyder Bulik Wednesday, July 11, 2018 Chief creative at winning agency talks creativity that leaps the old “good enough for pharma” bar.
Merck, Novartis and more make the Lions Health shortlist by Tracy Staton Monday, June 18, 2018 Pharma entries for Cannes Lions Health honors are at a record low, but a bigger-than-ever group of drugmakers made the short list.
Lions Health fills out juries for June's high-profile contest by Beth Snyder Bulik Wednesday, May 2, 2018 Cannes Lions Health has stocked its pharma and health & wellness juries, who'll sift entries in the two categories revamped for 2018.
FCB Health creates new branding agency by Beth Snyder Bulik Wednesday, March 21, 2018 As drugs roll into increasingly competitive markets, FCB Health has launched its first stand-alone branding agency focused on health and wellness.
New rules for Cannes Lions Health could boost pharma by Beth Snyder Bulik Monday, March 5, 2018 Will pharma creativity get a push from Cannes Lions Health? The festival has drawn lines between the pharma and health and wellness categories.
Snapchat and pharma: Could 3-second ads work? by Beth Snyder Bulik Monday, January 8, 2018 The door to Snapchat—and its millennial and Gen Z audiences—may open a bit wider for pharma if rumors about unskippable video ads prove true.
Kim Kardashian's back on Instagram backing Diclegis by Beth Snyder Bulik Wednesday, April 19, 2017 Kim Kardashian is back on social media plugging for pharma. This time, the FDA might like her Instagram post better, but Instagram followers weren't so positive.